General Information of the Compound
Compound ID
CP0081693
Compound Name
1-[[(2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy]-7-methoxyisoquinoline-6-carboxamide
    Show/Hide
Synonyms
PF-06650833
    Show/Hide
Structure
Formula
C18H20FN3O4
Molecular Weight
361.373
Canonical SMILES
CC[C@H]1[C@@H](COc2nccc3cc(C(N)=O)c(OC)cc23)NC(=O)[C@H]1F
    Show/Hide
InChI
InChI=1S/C18H20FN3O4/c1-3-10-13(22-17(24)15(10)19)8-26-18-11-7-14(25-2)12(16(20)23)6-9(11)4-5-21-18/h4-7,10,13,15H,3,8H2,1-2H3,(H2,20,23)(H,22,24)/t10-,13+,15-/m0/s1
    Show/Hide
InChIKey
JKDGKIBAOAFRPJ-ZBINZKHDSA-N
CAS
1817626-54-2
Physicochemical Property
logP
1.5838
Rotatable Bonds
6
Heavy Atom Count
26
Polar Areas
103.54
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 118414016
ChEMBL ID
CHEMBL4081711
DrugBank ID
DB15143
Clinical Information about the Compound
Drug 1 ( PF-06650833 )
Drug Name PF-06650833
Indication
Lupus
Phase 1